SYK Stryker Corp

  1. Stocks
  2. Healthcare
  3. NYSE: SYK

Price (delayed)

$335.61

Market cap

$127.62B

P/E Ratio

40.24

Dividend/share

$3.1

EPS

$8.34

Enterprise value

$137.64B

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; ...

Highlights
Stryker's EPS has increased by 34% YoY and by 22% from the previous quarter
SYK's net income is up by 34% year-on-year and by 22% since the previous quarter
SYK's debt is up by 2.4% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://www.stryker.com/
Peers: MDT BSX EW BAX

Key stats

What are the main financial stats of SYK
Market
Shares outstanding
380.26M
Market cap
$127.62B
Enterprise value
$137.64B
Valuations
Price to earnings (P/E)
40.24
Price to book (P/B)
6.86
Price to sales (P/S)
6.22
EV/EBIT
37.47
EV/EBITDA
33.85
EV/Sales
6.72
Earnings
Revenue
$20.5B
EBIT
$3.67B
EBITDA
$4.07B
Free cash flow
$3.14B
Per share
EPS
$8.34
Free cash flow per share
$8.26
Book value per share
$48.94
Revenue per share
$54
TBVPS
$52.89
Balance sheet
Total assets
$39.91B
Total liabilities
$21.32B
Debt
$13B
Equity
$18.59B
Working capital
$4.6B
Liquidity
Debt to equity
0.7
Current ratio
1.58
Quick ratio
0.86
Net debt/EBITDA
2.47
Margins
EBITDA margin
19.8%
Gross margin
63.7%
Net margin
15.4%
Operating margin
19%
Efficiency
Return on assets
8.3%
Return on equity
17.9%
Return on invested capital
16.6%
Return on capital employed
11.5%
Return on sales
17.9%
Dividend
Dividend yield
0.92%
DPS
$3.1
Payout ratio
37.2%

SYK stock price

How has the Stryker stock price performed over time
Intraday
-0.46%
1 week
3.13%
1 month
-4.22%
1 year
12.32%
YTD
12.07%
QTD
-6.22%

Financial performance

How have Stryker's revenue and profit performed over time
Revenue
$20.5B
Gross profit
$13.06B
Operating income
$3.89B
Net income
$3.17B
Gross margin
63.7%
Net margin
15.4%
The operating income has grown by 37% year-on-year and by 13% since the previous quarter
SYK's net income is up by 34% year-on-year and by 22% since the previous quarter
Stryker's operating margin has increased by 23% YoY and by 10% QoQ
SYK's net margin is up by 20% YoY and by 18% from the previous quarter

Growth

What is Stryker's growth rate over time

Valuation

What is Stryker stock price valuation
SYK P/E details
P/E
40.24
P/B
6.86
P/S
6.22
EV/EBIT
37.47
EV/EBITDA
33.85
EV/Sales
6.72
Stryker's EPS has increased by 34% YoY and by 22% from the previous quarter
SYK's P/E is 2.8% below its 5-year quarterly average of 41.4
SYK's P/B is 12% above its 5-year quarterly average of 6.1 and 11% above its last 4 quarters average of 6.2
SYK's equity is up by 12% year-on-year and by 3.8% since the previous quarter
The stock's price to sales (P/S) is 15% more than its 5-year quarterly average of 5.4 and 11% more than its last 4 quarters average of 5.6
The company's revenue rose by 11% YoY and by 3.1% QoQ

Efficiency

How efficient is Stryker business performance
Stryker's ROIC has increased by 42% YoY and by 14% from the previous quarter
The ROA has grown by 28% YoY and by 20% from the previous quarter
Stryker's ROS has increased by 23% YoY and by 11% from the previous quarter
The ROE rose by 21% YoY and by 19% QoQ

Dividends

What is SYK's dividend history
Dividend details
DPS
$3.1
Dividend yield
0.92%
Payout ratio
37.2%
Recent dividends

Financial health

How did Stryker financials performed over time
The total assets is 87% greater than the total liabilities
SYK's quick ratio is up by 23% from the previous quarter
The total assets has increased by 8% year-on-year and by 4.9% since the previous quarter
SYK's debt is 30% less than its equity
SYK's equity is up by 12% year-on-year and by 3.8% since the previous quarter
The debt to equity has contracted by 11% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.